Lv61
3080 积分 2024-04-17 加入
New Horizons of Model Informed Drug Development in Rare Diseases Drug Development
3小时前
已完结
Integrated Applied Clinical Pharmacology in the Advancement of Rare and Ultra‐Rare Disease Therapeutics
3小时前
已完结
Emergence of Small Nucleic Acids as Drugs in Precision Medicine
4小时前
已完结
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs
4小时前
已完结
Clinical and Quantitative Pharmacology Considerations of mRNA Therapeutics and Vaccine Development: Bridging Translational and Platform Gaps for Enhanced Decision Making
4小时前
已完结
Model‐Informed Dosing Strategies for Epcoritamab Monotherapy in Relapsed or Refractory Large B‐Cell Lymphoma
14天前
已完结
Deficiencies Delaying Prescription Drug Approvals by the U.S. Food and Drug Administration, 2020–2024
25天前
已完结
Epcoritamab Step-Up Dosing Regimen Selection and Optimization Using Repeated Time-to-Event Modeling for Cytokine Release Syndrome Risk Mitigation
1个月前
已完结
Machine Learning Prediction of Unbound Ceftriaxone Concentrations in Children: Capturing Developmental Changes in Protein Binding for Precision Dosing
1个月前
已完结
The Future of Clinical Translational Pharmacology
1个月前
已完结
皖公网安备34019202002308
